China’s MicroTech Medical seeks to raise $254m in Hong Kong IPO

Hangzhou-headquartered diabetes technology firm MicroTech Medical (Hangzhou) Co., Ltd is seeking to raise HK1.98 billion ($254 million) in its initial public offering (IPO) in Hong Kong.

MicroTech, which counts Lilly Asia Ventures (LAV) and Qiming Venture Partners among its investors, targets to sell up to 63.50 million shares at price between HK$27.70 ($3.56) and HK$31.15 ($4) apiece.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter